1 Epidemiologic Considerations in Screening -- 2 Maternal Red Blood Cell Group and Antibody Screen -- 3 Antepartum Assessment of Hemoglobin, Hematocrit, and Serum Ferritin -- 4 Postpartum Assessment of Hemoglobin, Hematocrit, and Serum Ferritin -- 5 Asymptomatic Bacteriuria in Pregnancy -- 6 Neonatal Group B Streptococcal Disease -- 7 Rubella During Pregnancy -- 8 Congenital Toxoplasmosis -- 9 Congenital Cytomegalovirus Infection -- 10 Hepatitis A, B, and C During Pregnancy -- 11 Syphilis -- 12 Gonorrhea -- 13 Chlamydial Infection -- 14 HIV Infection -- 15 Screening for Cystic Fibrosis Carrier Status -- 16 Screening for Hemoglobinopathies -- 17 Early-onset Genetic Disease -- 18 Screening for Fragile X Syndrome -- 19 Screening for Huntington Disease -- 20 Routine Ultrasound for Dating -- 21 First Trimester Screening for Aneuploidy -- 22 Second Trimester Screening for Aneuploidy (Ultrasound and Biochemistry) -- 23 Biochemical Screening for Fetal Abnormalities -- 24 Routine Ultrasonography for the Detection of Fetal Structural Anomalies -- 25 Molecular Tests for Antenatal Detection of Aneuploidy -- 26 Thrombophilia and Pregnancy Complications: Preeclampsia, (Late) Intrauterine Fetal Death, and Thrombosis -- 27 Screening for Autoimmune Diseases in Pregnancy -- 28 Gestational Diabetes Mellitus -- 29 Screening for Low Birth Weight Using Maternal Height and Weight -- 30 Fundal Height Measurement -- 31 Fetal Growth Restriction -- 32 Doppler Velocimetry for the Detection of Intrauterine Growth Restriction -- 33 Preterm Delivery -- 34 Preeclampsia: Blood Pressure, Weight Gain, and Edema -- 35 Uterine Artery Doppler as Screening Tool for Preeclampsia -- 36 Preeclampsia and Uric Acid -- 37 Fetal Hypoxia -- 38 Peripartum Coagulopathy -- 39 Postpartum Umbilical Cord Blood Testing -- 40 When to Screen for Neonatal Hypoglycemia -- 41 Neonatal Hyperbilirubinemia -- 42 Screening for Neonatal Genetic Disorders -- 43 The Annual Bimanual Examination -- 44 Dyslipidemia -- 45 Diabetes Mellitus -- 46 Screening Tests for Contraceptive Users -- 47 Genetic Predisposition to Gynecologic Cancers -- 48 Screening for Breast Cancer -- 49 Pap Smear -- 50 High-Risk Human Papillomavirus Testing in Cervical Cancer Screening -- 51 Transvaginal Ultrasound as a Screening Method for Ovarian Cancer -- 52 Serum CA-125 Screening for Ovarian Cancer -- 53 Screening for Colorectal Cancer -- 54 The Electrocardiogram -- 55 Intravenous Pyleography -- 56 Osteoporosis -- Index.
0
SUMMARY OR ABSTRACT
Text of Note
When to Screen in Obstetrics and Gynecology 2nd Edition, explains exactly when and how to screen for a wide variety of conditions ... addressing the fundamental questions you should consider in order to make informed decisions! Features a standardized format throughout to facilitate quick access to informationMakes a clear distinction between the characteristics of screening tests versus diagnostic testsOffers recommendations regarding the usefulness and acceptability of testing and preventative measures for both established and emerging settingsIncludes expanded coverage of large screening tests for Down Syndrome and cystic fibrosis.